Skip Navigation


Europace Advance Access originally published online on May 7, 2008
Europace 2008 10(7):825-831; doi:10.1093/europace/eun118
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
10/7/825    most recent
eun118v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Fored, C. M.
Right arrow Articles by Rosenqvist, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fored, C. M.
Right arrow Articles by Rosenqvist, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2008. For permissions please email: journals.permissions@oxfordjournals.org


Pacing

Atrial vs. dual-chamber cardiac pacing in sinus node disease: a register-based cohort study

C. Michael Fored1,*, Fredrik Granath1, Fredrik Gadler2, Paul Blomqvist1, Jenny Rynder3, Cecilia Linde2, Anders Ekbom1 and Mårten Rosenqvist3

1 Clinical Epidemiology Unit, Department of Medicine, Karolinska Institutet and Karolinska University Hospital, Site Solna M9:01, SE-171 76 Stockholm, Sweden; 2 Cardiology Unit, Department of Medicine, Karolinska Institutet and Karolinska University Hospital, Solna, Stockholm, Sweden; 3 Department of Cardiology, Stockholm Söder Hospital and Karolinska Institutet, Stockholm, Sweden

Aims: In patients with sinus node disease, dual-chamber pacing (DDD) possibly results in adverse effects on the ventricular function. We have compared the incidence of cardiovascular morbidity and mortality in patients with sinus node disease and with atrioventricular (AV) synchronous pacemakers, DDD vs. atrial pacing (AAI).

Methods and results: A nation-wide population-based cohort of 8777 patients with AAI- or DDD-mode pacemakers was followed during 12 years. The cohort was linked to national healthcare and census registers. Patients with DDD pacing and without any pre-implant admission for atrial fibrillation or flutter had an increased risk of post-implant fibrillation or flutter, in relation to corresponding AAA patients [hazard ratio (HR) = 1.30; 95% confidence interval (CI) 1.10–1.52]. A slight increase in the risk of any cardiovascular disease (HR = 1.07; CI, 1.00–1.15), and all-cause mortality (HR = 1.12; CI, 1.00–1.25), was seen among DDD patients, in relation to AAI patients, but there was no significant difference in the risk of ischaemic or unspecified stroke (HR = 1.14; CI, 0.94–1.37). Among DDD patients, the all-cause mortality did not differ from the general population [standardized mortality ratio (SMR) = 1.04; CI, 0.98–1.11]. Patients with AAI, however, had a decreased all-cause mortality risk (SMR = 0.89; CI, 0.82–0.97).

Conclusion: Our results support AAI as the preferred mode of pacing in patients with sinus node disease, and a normal AV node function.

Key Words: Arrhythmia, Sinoatrial node, Pacing, Stroke, Epidemiology


* Corresponding author. Tel: +46 8 517 791 81; fax: +46 8 517 793 04.E-mail address: Michael.Fored{at}ki.se

Manuscript submitted 18 February 2008. Accepted after revision 8 April 2008.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.